Sprains and Strains

7
Pipeline Programs
2
Companies
1
Clinical Trials
5
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
6
Early DiscoveryClinical DevelopmentMarket

On Market (5)

Approved therapies currently available

U
ACEPHENApproved
acetaminophen
Unknown Company
rectal1992
U
INFANTS' FEVERALLApproved
acetaminophen
Unknown Company
rectal1980
J&
INJECTAPAPApproved
acetaminophen
Johnson & Johnson
injection
U
OFIRMEVApproved
acetaminophen
Unknown Company
intravenous2010
U
TYLENOLApproved
acetaminophen
Unknown Company
oral1994

Competitive Landscape

2 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
1
acetaminophenPhase 41 trial
Active Trials
NCT00261560Completed260Est. Feb 2004
OD
1 program
1
tramadol HCl + acetaminophen; hydrocodone bitartrate + acetaminophen; placeboPhase 3

Clinical Trials (1)

Total enrollment: 260 patients across 1 trials

NCT00261560Johnson & Johnsonacetaminophen

A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.

Est. completion: Feb 2004260 patients
Phase 4Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space